I guess Bank of America felt left behind. This thing will probably go to $5,000 just on upgrades alone. What company needs to sell products when you can just let analysts tell you what the company is worth if by chance they were able to sell a product.
Now it's worth $6 Billion. Ha! Too funny! Priced at 6,000 X Revenue with a 10% chance they might have a drug FDA approved by 2017 or 2018.
If Weisel Jerkowitz and Schmuckler are giving it a $5,000 price target than it must be true.
Looks like I left out Insider Selling but dont worry because everytime the insiders sell they go ahead and give themselves more stock options and then once they realize they can dilute and do a secondary to give themselves even more stock options they will do that too.
So you are pumping a stock that isnt even through Phase III trials because you were dumb enough to by at $365. The FDA has an approval process and this company is years away from getting through that process. I bet you I can buy this stock in 2016 lower than I can buy it today and thats a fact jack.
Welcome to Biotech rookie.
and you will be living in your own personal sht_house since you decided to go all in on a typical wall street bio tech pump and dump.
If only they were selling drugs for Alcoholic Herpes, now that would be a blockbuster. You know that case of herpes you catch after you drank 6 beers and 5 irish car bombs and decide to kiss the chick at the bar who has what you decide is just a minor case of lip sores.
FACT: This drug is so far from being available for sale that the company will have at least 3 rounds of dilution before getting through the FDA approval process. Just ask yourself what another 5 million or so shares added to the float does to the share price.
P.S. Good luck getting through a Phase 3 trial on the first try. That disappointment should be worth about a 75% drop.
Because someone who is an alcoholic probably has money or insurance to pay for this drug when it finally does become available for sale in 2017 or 2018 (if ever).
How many alcoholics are so worried about their health that they go get annual checkups and liver biopsies on a regular basis?
$5 Billion market cap and they have nothing but a possibility of getting a drug through the FDA approval process... Good Luck bag holders!!!
Did you buy at $497 too? Just letting people know the game because I'm sure there are plenty of people lured into thinking that this stock is poised to go from $50 to $500 and then onto $1,000. It doesn't happen and for sure won't happen with this stock. If you had this stock below $75 and you didn't get out at $300 or $400 or even $497 then I guess you deserve the punishment you will get over the next 6 months.
Here is what Longs have to look forward to:
1) CEO and his minions getting stock options, pay raises and bonuses.
2) No drug through FDA approval process for at least 2 years.
3) No drug for sale for at least 3 years.
4) Dilution to raise money (see #1 above) and to cover R&D and everything else they can think of to waste shareholders money.
5)$100 share price or lower before all is said and down.
6) Shorts will rip your face off and make you wish you have never heard of this company.
Get ready to witness the ups and downs of a biotech stock getting through the FDA approval process and then watch them flounder around for another 2 years trying to sell this drug if they are lucky enough to get through the FDA approval process which is normally impossible on the first try.
That's a clown call bro! Apparently you have never witnessed the ups and downs of a biotech stock just getting through the FDA approval process (minimum of 2 years from now) and then watching them flounder around for another 2 years trying to sell the drug. All the while there will be round after round of dilution and more quarterly losses than you can stomach.
and it wont have any treatment for 3-4 years which how long it will take to get through FDA approval process and be available for sale. Prepare for dilution and massive insider selling to satisfy the greedy appetite of another greedy biotech CEO and his minions.
It may not be on Monday but the smart thing to do would be a 40 million share secondary at $100. There is no way they could do a secondary above that number and they will need the money since they have ZERO revenue for at least the next 3 years.
was that in bitcoin or did you get ruby's in your hay day game? The only person that owned ICPT was Tradestoxx and Jeandoyon, oh never mind they just wish laughing and crying pills were as big as liver disease pills.
If you were an insider you should dump every single share you own plus the company should do a secondary and dilute this thing just so they have enough money to not go bankrupt getting this drug through the FDA approval process and getting it for sale. That is a 2-4 year process I don't go what the pumpers errrrr bagholders say.
We see it everytime with biotech, sell on the news or become the next bagholder.
yep lost 10% more today didnt u? maybe you should cost average dollar down split...
Tradestoxx was buying above $5 in 2010 and is so far underwater in avanir he cant even see straight.
Still not profitable and still trying to treat crying and laughing disease with cough medicine ingredients. Only in America! With the shelf registration available to dilute this stock and have 200 million outstanding shares at least they can stay in business till the end of 2014.
Katkin has been stealing shareholders money since 2009, just do a search for "cafepharma avanir" to see the truth about Katkin.
even if pigs flew and they served ice water in he11 and somehow this was true the company still wouldnt be profitable and they would still need to dilute and use the shelf registration to take this to 200 million outstanding shares.
look up these ingrdients that are in Nuedexta, yes its simply cough medicine and they have been peddling this as a real drug to treat laughing and crying. How many of your friends, neighbors, relatives have laughing and crying disease? As these studies come in for other indicatins you will find they all say the same thing that it is no more effective than a placebo and you might as well take some Nyquil.
Nuedexta Ingredients: dextromethorphan and quinidine